Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Merck & Co., Inc.    MRK

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization1 153 304198 695231 557210 954210 954-
Entreprise Value (EV)1 169 216214 945247 453226 113223 339221 082
P/E ratio 60,5x32,9x23,9x17,6x15,6x14,5x
Yield 3,34%2,60%2,48%2,94%3,13%3,41%
Capitalization / Revenue 3,82x4,70x4,94x4,38x4,08x3,88x
EV / Revenue 4,22x5,08x5,28x4,69x4,32x4,07x
EV / EBITDA 11,2x13,6x12,6x11,4x10,3x9,50x
Price to Book 4,42x7,42x9,00x6,94x6,27x5,49x
Nbr of stocks (in thousands) 2 724 4372 600 3772 545 9842 530 0342 530 034-
Reference price (USD) 56,376,491,083,483,483,4
Last update 02/02/201802/01/201902/05/202012/21/202012/21/202012/21/2020
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales1 40 12242 29446 84048 20051 71354 308
EBITDA1 15 13115 78119 57219 88721 73423 268
Operating profit (EBIT)1 13 55113 92615 92017 39919 04220 976
Operating Margin 33,8%32,9%34,0%36,1%36,8%38,6%
Pre-Tax Profit (EBT)1 6 7478 70111 46414 78217 39117 933
Net income1 2 5686 2209 84312 14413 23913 809
Net margin 6,40%14,7%21,0%25,2%25,6%25,4%
EPS2 0,932,323,814,745,365,77
Dividend per Share2 1,881,992,262,452,612,84
Last update 02/02/201802/01/201902/05/202001/15/202101/15/202101/15/2021
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt1 15 91216 25015 89615 15912 38410 127
Net Cash position1 ------
Leverage (Debt / EBITDA) 1,05x1,03x0,81x0,76x0,57x0,44x
Free Cash Flow1 4 5598 3079 96712 33514 96516 248
ROE (Net Profit / Equities) 29,4%38,1%50,9%52,7%49,6%49,6%
Shareholders' equity1 8 74116 33519 34823 06326 68827 827
ROA (Net Profit / Asset) 11,9%13,6%11,8%15,8%16,4%18,2%
Assets1 21 52145 63183 51776 79380 61176 003
Book Value Per Share2 12,710,310,112,013,315,2
Cash Flow per Share2 2,354,085,215,817,917,39
Capex1 1 8882 6153 4733 1333 3003 499
Capex / Sales 4,71%6,18%7,41%6,50%6,38%6,44%
Last update 02/02/201802/01/201902/05/202001/07/202101/07/202101/04/2021
1 USD in Million
2 USD
Estimates
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Analysis
Merck to move COVID-19 treatment into large trials, sees sales recovering this year
Stock Pick
 MERCK AND COMPANY
Leader in oncology, modest valuation
Key data
Capitalization (USD)
210 954 271 357
Net sales (USD)
46 840 000 000
Number of employees
71 000
Sales / Employee (USD)
659 718
Free-Float
70,7%
Free-Float capitalization (USD)
149 077 263 799
Avg. Exchange 20 sessions (USD)
846 096 541
Average Daily Capital Traded
0,40%
EPS & Dividend
Year-on-year evolution of the PER
Help 
The blue ligne is the average P/E ratio (without estimates)
Year-on-year evolution of the Yield
Help 
The blue ligne is the average yield (without estimates)
Evolution Valeur d'Entreprise / EBITDA
Help 
The blue ligne is the average yield (without estimates)
Categories
Free services
Mobile App
SOLUTIONS
About
Stock Market Quotes Interactive brokers The best of tweets Stock Market News Börse: Aktien, Kurse und Nachrichten
Copyright © 2021 Surperformance. All rights reserved. Stock quotes are provided by Factset, Morningstar and S&P Capital IQ